Flortaucipir PET Imaging in Subjects With FTD

Exclusion Criteria

• •Have clinically significant cardiac, hepatic, renal, pulmonary, metabolic, or endocrine disturbances that pose potential safety risk
• •Have history of risk factors for Torsades de Pointes (TdP) or taking medication known to cause QT prolongation
• •Have history of drug or alcohol dependence within the last year
• •Are females of childbearing potential who are not surgically sterile, not refraining from sexual activity, or not using reliable contraception
• •Have history of relevant severe drug allergy or hypersensitivity
• •Have received an investigational medication under FDA IND protocol within 30 days of planned imaging session
• •Have received a radiopharmaceutical for imaging/therapy within 24 hours of imaging session
• •Possess PET scan evidence of amyloid deposition
• •Determined by the investigator to be unsuitable for this type of study